Poland· PL-100416424
Oscillococcinum
A medicinal product containing homeopatyczny produkt leczniczy, registered in Poland by Delfarma Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Homeopatyczny produkt leczniczy
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909991394943
- gtin05909991394950
- gtin05909991394967
- gtin05909991394974
- gtin05909991394981
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e69ad61e-2259-4baf-945a-6751a36011ab GET /v1/drugs/e69ad61e-2259-4baf-945a-6751a36011ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulki w pojemniku jednodawkowym",
"source": "urpl",
"strength": "-",
"packaging": "05909991394943 ¦ OTC ¦ 131259\n6 poj. 1 g jednodawkowych\n05909991394950 ¦ OTC ¦ 131260\n12 poj. 1 g jednodawkowych\n05909991394967 ¦ OTC ¦ 131261\n18 poj. 1 g jednodawkowych\n05909991394974 ¦ OTC ¦ 131262\n24 poj. 1 g jednodawkowych\n05909991394981 ¦ OTC ¦ 131263\n30 poj. 1 g jednodawkowych",
"substance": null,
"common_name": "Homeopatyczny produkt leczniczy",
"pl_product_id": "100416424",
"pozwolenie_nr": "58/19",
"auth_procedure": "IR",
"authorisation_validity": "2029-02-15"
}See everything about homeopatyczny produkt leczniczy.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.